Riskpilot← Back to searchSign inGet full accessUNION therapeutics A/S
A/SActiveCVR 33963750Tuborg Havnevej 18Research and experimental development on natural sciences and engineering · NACE 7210Est. 20112 employeeswww.uniontherapeutics.com
Revenue 2024
DKK 621K
-73% vs 2023
EBITDA margin
-12242.2%
+46% vs 2023
Equity ratio
-245.1%
Financial strength
Net profit 2024
DKK -98,9M
+42% vs 2023
| Revenue | DKK 621K | -73% |
| EBITDA | DKK -76M | +46% |
| Net profit | DKK -98,9M | +42% |
| Total assets | DKK 61,2M | -49% |
| Equity | DKK -150,1M | -144% |
| Employees | 2 | — |
Legal name
UNION therapeutics A/S
CVR number
33963750
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
10. oktober 2011
Share capital
DKK 763.278
Employees
2 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to direktører i forening eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive forsknings- og udviklingsvirksomhed inden for bioteknologi samt anden i forbindelse hermed stående virksomhed.
Address
Tuborg Havnevej 18
Phone
+4540103044
Email
info@uniontherapeutics.com
Website
www.uniontherapeutics.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 164 | 1.203 | 3.056 | 691 | 729 | 315 | 0 | 12 | 0 | 118.912 | 34.393 | 2.299 | 621 |
| Staff expenses | -47 | -916 | -2.132 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -35 | 287 | 924 | -289 | -520 | -6.123 | -7.818 | -12 | -64.342 | -37.810 | -130.883 | -140.410 | -76.024 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -14.129 | -52.742 | -19.632 | -11.702 |
| EBIT | -35 | 287 | 924 | -289 | -520 | -6.123 | -7.818 | -12 | -64.342 | -51.939 | -183.625 | -160.042 | -87.726 |
| Net financials | -2 | -0 | 5 | -1 | -1 | -132 | -851 | -5 | -21.911 | -9.562 | -36.133 | -14.743 | -16.491 |
| Profit before tax | -21 | 287 | 928 | -290 | -521 | -6.254 | -8.668 | -17 | -86.253 | -61.501 | -219.758 | -174.785 | -104.217 |
| Tax | 8 | -73 | 350 | -66 | -36 | -858 | -870 | -4 | -5.515 | -5.475 | -5.454 | -5.359 | -5.295 |
| Net profit | -29 | 359 | 578 | -224 | -485 | -5.397 | -7.798 | -13 | -80.738 | -56.026 | -214.304 | -169.426 | -98.922 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 81 | 1.787 | 3.094 | 246 | 776 | 3.717 | 4.395 | 52.293 | 69.878 | 284.925 | 185.675 | 120.190 | 61.214 |
| Equity | 51 | 410 | 988 | -71 | -195 | 1.944 | -5.294 | -38.308 | -58.685 | 49.380 | -27.688 | -61.599 | -150.064 |
| Long-term debt | 0 | 0 | 0 | 0 | 732 | 401 | 9.026 | 81.220 | 94.964 | 170.675 | 136.793 | 10.541 | 33.467 |
| Short-term debt | 30 | 1.377 | 2.106 | 316 | 238 | 1.371 | 663 | 9.381 | 33.599 | 64.870 | 76.570 | 171.248 | 177.811 |
| Total debt | 30 | 1.377 | 2.106 | 316 | 970 | 1.772 | 9.689 | 90.601 | 128.563 | 235.545 | 213.363 | 181.789 | 211.278 |
EBITDA margin
-12242.2%
This company
15.8%
Market median
-77582% vs market
20122024
Equity ratio
-245.1%
This company
38.2%
Market median
-742% vs market
20122024
Return on equity
-9892200000.0%
This company
18.4%
Market median
-53761956622% vs market
20122024
Net profit margin
-15929.5%
This company
8.1%
Market median
-196760% vs market
20122024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20122024
Debt / equity
1.41×
This company
0.62×
Market median
-127% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2011-10-10 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
RV Management | Management | 2017 | — | — |
KD Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
MO Management | Management | 2021 | — | — |
MH Management | Management | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2020 | — | — | |
| Chairman | 2016 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
OS | Chairman | 2017 | — | — |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2016 | — | — | |
| Board of Directors | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
MANJIN ApS | Company | 20.0% | 20.0% | 2023 |
VENDLER ApS | Company | 20.0% | 20.0% | 2023 |
T&W HOLDING A/S | Company | 5.0% | 5.0% | 2023 |
Pharmaway Invest ApS | Company | 5.0% | 5.0% | 2017 |
EAF Procedius K/S | Company | 5.0% | 5.0% | 2017 |
Manjin Holding ApS | Company | 20.0% | 20.0% | 2023 |
Vendler Alpha ApS | Company | 20.0% | 20.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MANJIN ApS
UNION therapeutics A/S Board members of UNION therapeutics A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rasmus Vendler Toft-Kehler | Management | 0 companies |
| Kim Domela Kjøller | Chief Executive Officer | 0 companies |
| Morten Otto Alexander Sommer | Management | 0 companies |
| Morten Højland Boesen | Management | 0 companies |
| Stig Løkke Pedersen | Chairman | 0 companies |
| Astrid Sommer | Chairman | 0 companies |
| Gitte Pugholm Aabo | Board of Directors | 0 companies |
| Arthur Joseph Higgins | Board of Directors | 0 companies |
| Ole Skov | Chairman | 0 companies |
| Jutta Monika Heim | Board of Directors | 0 companies |
| Peter Kristensen | Board of Directors | 0 companies |
| Anne Katrine Toft-Kehler | Board of Directors | 0 companies |
| Andrew John Oakley | Board of Directors | 0 companies |